Sato acquires Magellan Technology

Published: 27-Nov-2013
Packaging

Adds Magellan Phase Jitter Modulation RFID technology to portfolio


Sato, a Japanese specialist in barcode printing, labelling, and EPC/RFID solutions, has acquired Magellan Technology, an Australian pioneer of RFID (Radio Frequency Identification) technology with its PJM (Phase Jitter Modulation) radio frequency data transmission technology, boosting its offerings in the track and trace sector.

No financial details have been revealed.

Sato will complete the purchase of Sydney-based Magellan’s healthcare business and all intellectual property early next month.

Sato Holdings Corporation has established Sato Vicinity, a 100% subsidiary, in NSW, Australia, as its new entity for the business acquired from Magellan. It is expected to start operation from mid-December.

'Magellan’s advanced RFID technology will put Sato in a totally unique position in the healthcare market,' said Kaz Matsuyama, President and CEO of Sato Holdings. 'In the healthcare sector, we will be the only company who has proprietary end-to-end RFID technologies incorporating RFID Chips and Tags, RFID Printers, and RFID Readers. A one-stop company offering efficient and accurate traceability solutions.'

Sato has been providing RFID solutions to the global market for more than a decade and recently became a business partner of Magellan Technology and started providing PJM RFID solutions in Japan.

  • Companies:
  • Sato Group
See more

You may also like

Manufacturing

Leybold launches Duradry vacuum pump for harsh processes

Read more
Advanced technology designed for reliability and efficiency

Trending Articles

  1. AstraZeneca to stop production of Pulmicort pMDI Agreements with SkyePharma expected to be terminated
  2. Knowledge and adaptability drive successful pharmaceutical outsourcing partnerships Third-party contract manufacturers and packers play an increasingly prominent role in the pharmaceutical sector, helping companies to both navigate the complexities of the market and capitalise on new opportunities
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Prefilled syringes: glass or polymer? Prefilled syringes come in many varieties with the most fundamental difference being the material they are made of – glass or polymer. Manufacturer Schott considers how to make the right choice
  4. Understanding the real risks of packaging When it comes to GMP production, specifying the type of packaging to be taken into the cleanroom is an important consideration. Dr Christoph Strubl, Managing Director of packaging company STRUBL, discusses the need for specialised cleanroom packaging
  5. Schott Pharma AG and Co. KGaA Advanced Drug Containment and Delivery Solutions from SCHOTT Pharma

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Manufacturing

Leybold launches Duradry vacuum pump for harsh processes

Advanced technology designed for reliability and efficiency
Packaging

How pharma packaging manufacturers role is evolving: the case of extractables testing

As the pharmaceutical industry continues to grow and evolve, extractables testing is a critical component of the pharmaceutical industry's efforts to prioritise quality and safety, ensuring one of the key functions pharma containers are designed for, says Anna Malori, Head of Product Management at Bormioli Pharma
Packaging

Dual-chamber packaging systems as a simplification factor in the supply chain

Dual-chamber packaging solutions could represent a new frontier also to package parenteral drugs, simplifying the supply chain through reconstitution, potentially making logistics more flexible and efficient, says Cecilia Bassi, Product Manager at Bormioli Pharma
Packaging

Bormioli Pharma to digitise package leaflets using augmented reality

The project is part of the Bormioli Pharma Invents innovation programme, which aims to provide concrete answers to some of the most important challenges in the pharmaceutical packaging sector.
Packaging

How augmented reality could impact healthcare and pharma packaging manufacturing

Research and Markets predicts a consistent growth for the AR market in healthcare over the next few years. The expected value of the AR market is projected to reach 152 billion dollars by 2030
Packaging

Navigating regulatory challenges in pharmaceutical packaging: lessons from the past and strategies for the future

To safeguard drug efficacy, maintain strict quality standards and ensure patient safety, pharmaceutical packaging is subject to a wide range of regulations around the world, reports Kun Shing Chan, Director of QA at Tjoapack
Packaging

Optima in the top 1% of pharmaceutical packaging companies for sustainability

The company has received the EcoVadis platinum award for its sustainability
Subscribe now